VSMC-Specific TRPC1 Deletion Attenuates Angiotensin II-Induced Hypertension and Cardiovascular Remodeling

0
126
Investigators found increased transient receptor potential canonical 1 (TRPC1) expression in angiotensin II (AngII)- treated vascular smooth muscle cells (VSMCs) and aortas from angiotensin II-infused mice.
[Journal of Molecular Medicine]
Abstract